MS Aapro, DA Cameron, R Pettengell, J … - European journal of cancer, 2006 - Elsevier Chemotherapy-induced neutropenia is not only a major risk factor for
infection-related morbidity and mortality, but is also a significant
dose-limiting toxicity in cancer treatment. Patients developing severe ... Cited by 139 - Related articles - All 8 versions
L Leibovici, M Paul, M Cullen, G Bucaneve, A … - CA A Cancer Journal for Clinicians - interscience.wiley.com New evidence shows that antibiotic prophylaxis in neutropenic patients reduces
mortality, febrile episodes, and bacterial infections. For patients with acute
leukemia or those who undergo bone marrow transplantation, prophylaxis with ... Cited by 42 - Related articles - BL Direct - All 4 versions
- ►jcojournal.org JNH Timmer-Bonte, EMM Adang, HJM Smit, B … - Journal of Clinical Oncology, 2006 - jcojournal.org PURPOSE: Recently, a Dutch, randomized, phase III trial demonstrated that, in
small-cell lung cancer patients at risk of chemotherapy-induced febrile
neutropenia (FN), the addition of granulocyte colony-stimulating factor ... Cited by 31 - Related articles - All 12 versions
- ►shouxi.net LR Baden - New England Journal of Medicine, 2005 - content.nejm.org Improved management of infectious complications of cancer has contributed
substantially to the success of care over the past several decades. In the 1960s
it became clear that neutropenia was highly correlated with the occurrence ... Cited by 30 - Related articles - BL Direct - All 6 versions
- ►oxfordjournals.org G Von Minckwitz, S Kummel, A du Bois, W … - Annals of Oncology, 2008 - Eur Soc Med Oncology Patients and methods: Patients with stage T2–T4 primary breast cancer were
scheduled to receive 6–8 cycles of TAC. Primary prophylaxis was: ciprofloxacin
500 mg orally twice daily on days 5–14 (n = 253 patients; 1478 cycles), ... Cited by 22 - Related articles - BL Direct - All 7 versions
- ►haematologica.it [PDF] M Brugiatelli, G Bandini, G Barosi, F Lauria, V … - haematologica, 2006 - haematologica.org Objectives. The Italian Society of Hematology (SIE) and two affiliate societies
(SIES and GITMO) commissioned a project to develop clinical practice guidelines
for the treat- ment of chronic lymphocytic leukemia (CLL). Methods. Key ... Cited by 20 - Related articles - BL Direct - All 19 versions
- ►annals.org [PDF] L Sung, PC Nathan, SMH Alibhai, GA … - Annals of Internal Medicine, 2007 - Am Coll Physicians Background: Benefits of prophylactic hematopoietic colony-stimu- lating factors
(CSFs) in adults and children receiving cancer chemo- therapy or undergoing
stem-cell transplantation (SCT) are unclear. ... Purpose: To determine ... Cited by 20 - Related articles - BL Direct - All 4 versions
N Lo, M Cullen - Hematological Oncology-Chichester, 2006 - interscience.wiley.com The use of antibiotic prophylaxis in neutropenic patients remains controversial.
The main arguments against prophylaxis are the lack of survival benefit and the
risk of inducing antibiotic resistance. At present, clinical guidelines ... Cited by 18 - Related articles - BL Direct - All 2 versions
- ►oxfordjournals.org [PDF] A Gafter-Gvili, M Paul, A Fraser, L Leibovici - Journal of Antimicrobial Chemotherapy, 2007 - Br Soc Antimicrob Chemo Page 1. Journal of Antimicrobial Chemotherapy (2007) 59, 5–22 doi:10.1093/
jac/dkl425 Advance Access publication 30 October 2006 ... Cited by 18 - Related articles - BL Direct - All 6 versions
- ►oxfordjournals.org H Von Baum, A Sigge, M Bommer, WV Kern, R … - Journal of Antimicrobial Chemotherapy, 2006 - Br Soc Antimicrob Chemo Patients and methods: In this controlled before and after observational study,
moxifloxacin chemoprophylaxis was used during prolonged neutropenia in
haemato-oncological patients (period 2; 282 episodes). Data were compared ... Cited by 15 - Related articles - BL Direct - All 7 versions
